Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
US8399423B2 · kind B2 · utility
7Cited by
4References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2008 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | May 29, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16011
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides the use of immune regulatory oligonucleotides (IRO) as antagonist of TLRs in the prevention and treatment of a disease caused by a pathogen, for example, a DNA or RNA virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.